Cargando…
Research progress on GP73 in malignant tumors
Malignant cancer is one of the most serious diseases that currently endanger human health. As most tumors are diagnosed at an advanced stage, the current treatments show poor therapeutic efficacy, and the patients have poor prognosis. However, a 5-year survival rate higher than 80% could be achieved...
Autores principales: | Liang, Rong, Liu, Ziyu, Piao, Xuemin, Zuo, Mingtang, Zhang, Jinyan, Liu, Zhihui, Li, Yongqiang, Lin, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204869/ https://www.ncbi.nlm.nih.gov/pubmed/30425529 http://dx.doi.org/10.2147/OTT.S181239 |
Ejemplares similares
-
GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021) -
GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells
por: Ye, Jia-Zhou, et al.
Publicado: (2018) -
GP73 is down-regulated in gastric cancer and associated with tumor differentiation
por: Chen, Le-Gao, et al.
Publicado: (2013) -
Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015) -
Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)